Low-weight syndrome associated with COPD in our setting;Síndrome de bajo peso asociado a la EPOC en nuestro medio

Archivos de Bronconeumologia

Volumn 38, Issue 12, 2002, Pages 580-584

  Coronell, C ^a   Orozco Levi, M ^a   Ramirez Sarmiento A ^a   Martinez Llorens J ^a   Broquetas, J ^a   Gea, J ^a,b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

COPD; Nutrition; Patient characteristics

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GEOGRAPHIC DISTRIBUTION; HUMAN; LIFE EXPECTANCY; LOW WEIGHT SYNDROME; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DISORDER; PHYSICAL ACTIVITY; PREVALENCE; REFERENCE VALUE; WEIGHT REDUCTION;

EID: 0036942909     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(02)75294-0     Document Type: Article

References (26)

1. Pena VS, Miravitlles M, Gabriel R, Jimenez-Ruiz CA, Villasante C, Masa JF, et al. Geographic variations in prevalence and under-diagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981-9.
2. Postma DS, Siafakas NM. Management of chronic obstructive pulmonary disease. Eur Respir J 1998;3:1.
3. Postma DS, Vermeire P. The natural history of chronic obstructive pulmonary disease. Eur Respir Mon 1998;3:74-83.
4. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61.
5. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am J Respir Crit Care Med 1989;139:1435-8.
6. Schols AMW, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-7.
7. Agustí AGN. El síndrome de Lázaro o la EPOC resucitada. Arch Bronconeumol 2001;37:3-6.
8. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, and The GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
9. 2 as predictors of health care resources utilization (HCRU). Am J Respir Crit Care Med 2000;161:A749.
10. Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1414-8.
11. Schols AMWJ, Soeters PB, Dingemans MC, Mostert R, Frantzen PJ, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am J Respir Crit Care Med 1993;147:1151-6.
12. Wilson DO, Rogers RM, Hoffman RM. Nutrition and chronic lung disease. Am Rev Respir Dis 1985;132:1347-65.
13. Pride NB, Vermeire P. Definition and differential diagnosis. In: Postma DS y Siafakas NM, editors, Management of chronic obstructive pulmonary disease. Sheffield: Eur Resp Soc J, 1998; p. 2-5.
14. Roca J, Sanchís J, Agustí-Vidal A, Segarra F, Navajas D, Rodríguez-Roisín R, et al. Spirometric reference values for a Mediterranean population. Bull Eur Physiopathol Resp 1986;22:217-24.
15. Roca J, Burgos F, Barberá JA, et al. Prediction equations for plethysmographic lung volumes. Respir Med 1998;92:454-60.
16. Roca J, Rodríguez-Roisín R, Cobo E, Burgos F, Pérez J, Clausen JL. Single-breath carbon monoxide diffusing capacity (DLco) prediction equations for a Mediterranean population. Am Rev Respir Dis 1990;14:1026-32.
17. Debigaré R, Coté H, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1712-7.
18. American Thoracic Society and European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999;159:S1-40.
19. Francia MD, Barbier D, Mege JL, Orejek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;150:1453-5.
20. Barreiro E, Gea J, Palacio J, Hussain SNA. Expression of nitric oxide synthases (NOS) in quadriceps of COPD patients. Eur Respir J 2001;18(Suppl 33):S423.
21. Palacio J, Gáldiz JB, Bech JJ, Mariñán M, Casadevall C, Martínez-Ramírez P, et al. Expresión de los genes codificadores de la interleuquina 10 (IL-10) y factor de necrosis tumoral alfa (TNF-α) en los músculos respiratorios y periféricos. Relación con el daño sarcolémico. Arch Bronconeumol 2002;38:311-6.
22. Heyer E, Tremblay M. Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am J Hum Genet 1995;56:970-8.
23. Masia R, Pena A, Marrugat J, Sala J, Vila J, Pavesi M, et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health 1998;52:707-15.
24. Schols AMWJ, Wousters EFM, Soeters PB, Westertep KR. Body composition by bioelectrical impedance analysis compared to deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 53:421-4.
25. Andreoli A, Melchiorri G, De Lorenzo A, Caruso I, Sinibaldi Salimei P, Guerrisi M. Bioelectrical impedance measures in different position and versus dual-energy X-ray absorptiometry (DXA). J Sports Med Phys Fitness 2002;42:186-99.
26. Barendregt K, Cox-Reijven PL, Hogen EVE, Beijer S, Geerlings P, Soeters PB. Case study of the clinical usefulness of bioelectrical impedance spectroscopy in evaluating nutritional status. J Hum Nutr Diet 2002;15:189-92.